BioNTech is a biotech company with a strong cash position and a commercial program generating cash flow, making it a promising investment opportunity. The company's pipeline includes programs ...
A new variant of the coronavirus has become dominant, supplanting other versions of the virus. This is why the Emergency Task ...
The ministry also encouraged all who are aged 6 months and above to get vaccinated a year after their last dose. Read more at ...
The EU's drug watchdog urged that anti-COVID-19 jabs be updated before another round of vaccinations to counter a new variant ...
A new study shows that immunity after a COVID-19 booster lasts much longer than the primary series alone. These findings are among other, sometimes 'unintuitive,' revelations of how factors like age, ...
Dr Heather Shaw, national co-ordinating investigator, says the jab is being tested to see if it can work for lung, bladder ...